We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fidget Spinner Rapidly Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 16 Jun 2020
Print article
Image: A fidget spinner for the point-of-care diagnosis of urinary tract infection (Photo courtesy of Ulsan National Institute of Science and Technology).
Image: A fidget spinner for the point-of-care diagnosis of urinary tract infection (Photo courtesy of Ulsan National Institute of Science and Technology).
More than half of all women experience at least one episode of urinary tract infection (UTI) in their lifetime, with men also facing increasing risks of infection as they age. Current detection of UTIs relies on patients reporting symptoms followed by a laboratory culture of the urine for known bacterial culprits, which typically takes a few days.

Doctors tend to prescribe antibiotics to suppress any suspect cases of UTI before they get the test results, contributing to the increasing problem of antibiotic resistance. Dipstick tests that reduce the time taken for diagnoses come with a high chance for false positives. The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate.

A multidisciplinary and international team of scientists led by the Ulsan National Institute of Science and Technology (Ulsan, Republic of Korea) developed a fidget spinner-based device to detect UTIs from urine samples. The device was field tested on 39 patients in Tiruchirappalli, India who would have all been given antibiotics based on their symptoms alone. The team reported 59% of the patients were found to be over/under-treated with antibiotics, something that can be rectified using this novel device.

The custom-made fidget spinner rapidly concentrates pathogens in 1-mL samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. The test of the rectangular device with one or two nudges spins for a long time pushing any bacteria onto a membrane. This is then dyed, with a color change visible to the naked eye in less than one hour, which indicates the amount of bacterial load.

The device enabled the on-site detection of infection with the naked eye within 50 minutes in urine samples from the patients suspected of having a urinary tract infection. The team also showed that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 minutes.

Another test gave a preliminary indication of the presence of antibiotic resistance. By testing the spun samples treated with different drugs and comparing them to untreated samples, the team was able to quickly make a decision on which antibiotic might work best to treat the UTI. While this does not compare to laboratory based tests for microbial resistance, it is still a useful add-on for resource poor settings that do not typically test for resistance.

The authors concluded that the test can be performed by novices and that there is no extensive training that is required to learn how to spin the device and read the results. The ease-of-use, low price point, availability of quick results, and immediate benefits such as reduction in prescription of antibiotics, makes the new spinner an attractive alternative for diagnosing UTIs. The study was published on May 18, 2020 in the journal Nature Biomedical Engineering.

Related Links:
Ulsan National Institute of Science and Technology

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.